MGI Tech Launches VisiOmics in Europe and Unveils AI-Enabled Pathology Portfolio at ECP 2026

From Tissue to Answer: Integrated Solutions for Tissue and Molecular Pathology, from multiplex immunofluorescence to sample-to-result sequencing, powered by AI STOCKHOLM, Sept. 15, 2026 /PRNewswire/ -- MGI Tech Co., Ltd. (MGI), a company committed to developing core tools and technologies...